SCHEDULE: Investor Glibert Takes 22% Stake in ENvue Medical

Christian Glibert has acquired a 22% beneficial ownership stake in ENvue Medical, Inc. for investment purposes.

Summary

• Christian Michael Glibert acquired 240,000 shares of ENvue Medical, Inc. Common Stock.
• The acquisition represents approximately 22.0% of the company's outstanding common stock, based on 1,088,192 shares outstanding as of February 2026.
• The total cost of the acquisition was $640,737.85, funded entirely by Glibert's personal funds.
• The shares were purchased on January 14, 2026, in an open market transaction at an average price of $2.67 per share.
• The purpose of the transaction is for investment, and Glibert may acquire additional securities or dispose of existing holdings depending on market conditions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive, as a significant individual investment often signals confidence in the company's future prospects, though it does not provide operational or financial performance details.

Positives

• A significant individual investor, Christian Glibert, has acquired a substantial 22.0% stake in ENvue Medical, Inc., potentially signaling strong confidence in the company's future.

Risks

• The Reporting Person may, from time to time, dispose of all or a portion of the securities, which could exert downward pressure on the stock price.

Future Outlook

The Reporting Person, Christian Glibert, acquired the shares for investment purposes and may, depending on market conditions and other factors, acquire additional securities or dispose of all or a portion of the securities in the future. No other specific forward-looking statements from the company are provided in this filing.

Management Comments

• Christian Glibert acquired the Common Stock for investment purposes.
• Glibert has no present plans or proposals which relate to or would result in any corporate actions such as mergers, liquidations, or changes to the board of directors.

Industry Context

StockSavvy.ai notes that a significant individual stake acquisition, such as this 22% beneficial ownership, can sometimes signal strong conviction in a company's valuation or future prospects. While this filing does not detail operational changes, such a substantial investment by an individual can attract further investor attention to ENvue Medical, Inc.

Stakeholder Impact

• Shareholders may view this significant investment by Christian Glibert as a positive indicator of confidence in ENvue Medical, Inc.'s value, potentially influencing market sentiment.

Next Steps

• Christian Glibert may acquire additional securities of ENvue Medical, Inc. in the future.
• Christian Glibert may dispose of all or a portion of the securities of ENvue Medical, Inc. in the future.

Key Dates

Recommendation

The acquisition of a significant 22% stake by an individual investor, Christian Glibert, signals a strong belief in ENvue Medical, Inc.'s value. However, without further operational or financial details from the company, a 'hold' recommendation is prudent, as the filing primarily discloses ownership rather than fundamental performance.

Keywords

ENvue Medical, Christian Glibert, Schedule 13D, beneficial ownership, stock acquisition, investment, common stock